Stay updated on Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page
- Check7 days agoChange Detected- Revision updated from v3.5.4 to v3.5.5, indicating a small update to the page's metadata/formatting rather than to the study content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now includes a new revision tag, v3.5.4, replacing the previous v3.5.3, signaling a minor update to the page's revision history. This change is administrative and does not alter the study details or outcomes.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page footer revision has been updated from v3.5.2 to v3.5.3, indicating a minor site software/version update rather than a change to the clinical study information.SummaryDifference0.1%

- Check56 days agoChange Detected- Revision updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.1%

- Check85 days agoChange Detected- Added Revision: v3.5.0 to the Study Documents. - Removed Revision: v3.4.3.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous v3.4.2. This is a minor update to the page metadata and does not impact the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.